Spring 2020 Vol. 10 Issue 01
-
From the Editor-in-Chief
Cancer Epigenetics: Disorganization Drives DysfunctionEmerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
by William G. Nelson, MD, PhD
-
Forward Look
Cryoablation May Be a Treatment Option for Some Patients | Makers of E-Cigarettes Tout Role in Smoking Cessation | More Options to Prevent Blood Clots in High-Risk Cancer Patients | New Guidelines for Radiation Therapy in Pancreatic Cancer | Managing Opioid-Related Constipation | Getting Help to Avoid Financial Distress | What’s Next? Spring 2020
-
Your Cancer Guide
Weighing Treatment Options for Advanced CancerPatients with metastatic disease need to carefully consider risks and benefits of therapies within the context of their goals.
by Hester Hill Schnipper
-
Caregiving With Confidence
Strategies for Effective CommunicationWhen families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
-
Policy Matters
Taking Steps to Address Cancer Health DisparitiesCancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
-
Can CRISPR Deliver?A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
-
The Puzzle of Pancreatic CancerPancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
-
Survivor Profile
A Driving ForceMark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
-
Advocacy in Action
Leaving a LegacyTwo mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
-
-
Q&A
A Different MountaintopScience writer Charles Graeber describes how a shift in researchers' understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersExperts offer advice on getting involved with patient advocacy, expressing feelings to loved ones, and hospice care.
-
Get Involved
Filling a VoidA mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.
by Elizabeth Rosto Sitko
-
In the Moment – Spring 2020Readers share snapshots of their lives today.
Families who travel far for treatment may face financial toxicity and insurance hurdles.
by Thomas Celona
Rural Women With Breast Cancer Face Increased Mortality RiskBreast cancer mortality rates have declined overall, but women who live in rural areas have not experienced the same progress as those in more populated areas.
by Thomas Celona
Targeted Therapy Approval Adds Option for Advanced Breast Cancer Without MutationA new treatment for people with hormone receptor-positive, HER2-negative disease blocks multiple proteins in a key pathway for treatment resistance.
by Ashley P. Taylor
Amanda Peet Discusses Her Lobular Breast Cancer DiagnosisThe ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
